We provide you with 20 years of free, institutional-grade data for PTGX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PTGX. Explore the full financial landscape of PTGX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$3,941,611
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Waddill William D. | Sale | -4,000 | $64.25 | $257,000 | 2025-09-24 |
| Waddill William D. | Sale | -4,000 | $59.25 | $237,000 | 2025-08-29 |
| PATEL DINESH V PH D | Sale | -10,415 | $54.78 | $570,534 | 2025-07-28 |
| PATEL DINESH V PH D | Sale | -52,444 | $54.86 | $2,877,078 | 2025-07-23 |
| PATEL DINESH V PH D | Grant, award...etc | 25,000 | 2025-07-23 | ||
| MOLINA ARTURO MD | Sale | -20,000 | $55.51 | $1,110,200 | 2025-06-11 |
| MOLINA ARTURO MD | Derivatives Exercise | 20,000 | 2025-06-11 | ||
| SELICK HAROLD E | Derivatives Exercise | 10,725 | 2025-04-30 | ||
| Ali Asif | Sale | -1,756 | $46 | $80,776 | 2025-04-23 |
| Waddill William D. | Sale | -4,000 | $54.25 | $217,000 | 2025-03-19 |
| Ali Asif | Sale | -24,903 | $58.73 | $1,462,553 | 2025-03-14 |
| Ali Asif | Derivatives Exercise | 24,903 | 2025-03-14 | ||
| MOLINA ARTURO MD | Sale | -30,514 | $55.74 | $1,700,850 | 2025-03-14 |
| MOLINA ARTURO MD | Derivatives Exercise | 30,514 | 2025-03-14 | ||
| PATEL DINESH V PH D | Derivatives Exercise | 24,000 | 2025-03-05 | ||
| PATEL DINESH V PH D | Sale | -5,359 | $38.18 | $204,607 | 2025-02-20 |
| MOLINA ARTURO MD | Sale | -3,640 | 2025-01-17 | ||
| Ali Asif | Sale | -3,918 | 2025-01-17 | ||
| PATEL DINESH V PH D | Sale | -12,636 | 2025-01-17 | ||
| MOLINA ARTURO MD | Grant, award...etc | 41,088 | 2025-01-06 | ||
| PATEL DINESH V PH D | Grant, award...etc | 149,800 | 2025-01-06 | ||
| Giraudo Bryan | Grant, award...etc | 5,130 | 2025-01-06 | ||
| Ali Asif | Grant, award...etc | 31,779 | 2025-01-06 | ||
| O'Dowd Sarah A | Grant, award...etc | 5,130 | 2025-01-06 | ||
| Williams Lewis T | Grant, award...etc | 5,130 | 2025-01-06 | ||
| Waddill William D. | Grant, award...etc | 5,130 | 2025-01-06 | ||
| SELICK HAROLD E | Grant, award...etc | 5,130 | 2025-01-06 | ||
| Gupta Suneel | Sale | -122,628 | $46.04 | $5,645,793 | 2024-11-27 |
| Gupta Suneel | Derivatives Exercise | 205,450 | 2024-11-27 | ||
| MOLINA ARTURO MD | Sale | -31,529 | $45.6 | $1,437,722 | 2024-11-27 |
| MOLINA ARTURO MD | Derivatives Exercise | 31,529 | 2024-11-27 | ||
| PATEL DINESH V PH D | Derivatives Exercise | 1,727 | 2024-11-27 | ||
| PATEL DINESH V PH D | Sale | -100,000 | $46.96 | $4,696,000 | 2024-11-27 |
| MOLINA ARTURO MD | Sale | -1,906 | $40.98 | $78,108 | 2024-11-19 |
| Ali Asif | Derivatives Exercise | 12,000 | 2024-09-13 | ||
| Ali Asif | Sale | -14,203 | $44.59 | $633,312 | 2024-09-13 |
| Waddill William D. | Sale | -8,000 | $45 | $360,000 | 2024-09-12 |
| Waddill William D. | Derivatives Exercise | 8,000 | 2024-09-12 | ||
| Waddill William D. | Sale | -8,000 | $40 | $320,000 | 2024-07-26 |
| Waddill William D. | Derivatives Exercise | 8,000 | 2024-07-26 | ||
| Waddill William D. | Sale | -8,000 | $35 | $280,000 | 2024-06-11 |
| Waddill William D. | Derivatives Exercise | 8,000 | 2024-06-11 | ||
| PATEL DINESH V PH D | Sale | -35,000 | $35.19 | $1,231,650 | 2024-06-11 |
| Ali Asif | Sale | -1,234 | $25.11 | $30,986 | 2024-04-19 |
| PATEL DINESH V PH D | Sale | -25,000 | $28.31 | $707,750 | 2024-04-02 |
| Ali Asif | Derivatives Exercise | 12,000 | 2024-03-01 | ||
| Ali Asif | Sale | -24,187 | $30.61 | $740,364 | 2024-03-01 |
| Waddill William D. | Sale | -12,975 | $31.34 | $406,637 | 2024-03-01 |
| Waddill William D. | Derivatives Exercise | 12,975 | 2024-03-01 | ||
| PATEL DINESH V PH D | Sale | -30,000 | $31.62 | $948,600 | 2024-03-01 |
| PATEL DINESH V PH D | Sale | -10,915 | $29.53 | $322,320 | 2024-02-28 |
| Gupta Suneel | Sale | -4,282 | $29.53 | $126,447 | 2024-02-28 |
| PATEL DINESH V PH D | Sale | -3,717 | $28.23 | $104,931 | 2024-02-20 |
| MOLINA ARTURO MD | Sale | -427 | $24.63 | $10,517 | 2024-01-18 |
| Ali Asif | Sale | -1,452 | $24.63 | $35,763 | 2024-01-18 |
| Gupta Suneel | Sale | -5,000 | $25 | $125,000 | 2024-01-11 |
| Gupta Suneel | Derivatives Exercise | 5,000 | 2024-01-11 | ||
| MOLINA ARTURO MD | Grant, award...etc | 26,250 | 2024-01-04 | ||
| MOLINA ARTURO MD | Sale | -1,848 | $16.24 | $30,012 | 2024-01-04 |
| PATEL DINESH V PH D | Grant, award...etc | 84,875 | 2024-01-04 | ||
| Ali Asif | Grant, award...etc | 21,000 | 2024-01-04 | ||
| Gupta Suneel | Grant, award...etc | 19,250 | 2024-01-04 | ||
| PATEL DINESH V PH D | Sale | -75,000 | $20.08 | $1,506,000 | 2023-12-15 |
| Gupta Suneel | Derivatives Exercise | 20,000 | 2023-10-23 | ||
| PATEL DINESH V PH D | Derivatives Exercise | 6,000 | 2023-10-19 | ||
| Gupta Suneel | Sale | -4,150 | $26.07 | $108,191 | 2023-06-02 |
| Gupta Suneel | Grant, award...etc | 12,000 | 2023-06-02 | ||
| PATEL DINESH V PH D | Sale | -12,165 | $26.07 | $317,142 | 2023-06-02 |
| PATEL DINESH V PH D | Grant, award...etc | 30,000 | 2023-06-02 | ||
| Ali Asif | Sale | -4,150 | $26.07 | $108,191 | 2023-06-02 |
| Ali Asif | Grant, award...etc | 12,000 | 2023-06-02 | ||
| Ali Asif | Sale | -1,189 | $23.21 | $27,597 | 2023-04-19 |
| SELICK HAROLD E | Derivatives Exercise | 6,196 | 2023-04-11 | ||
| Ali Asif | Grant, award...etc | 10,625 | 2023-01-18 | ||
| Gupta Suneel | Grant, award...etc | 20,625 | 2023-01-18 | ||
| MOLINA ARTURO MD | Grant, award...etc | 3,125 | 2023-01-18 | ||
| Liu David Y | Derivatives Exercise | 100,479 | 2022-11-17 | ||
| MOLINA ARTURO MD | Grant, award...etc | 21,250 | 2022-11-17 |
The information provided in this report about PTGX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Protagonist Therapeutics, Inc(NASDAQ:PTGX) 
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythem...
Website: http://www.protagonist-inc.com
Founded: 2006
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology